Here, using genetically modified mouse models, human AAA tissue, and oxylipidomics, we demonstrate that the eoxPL/Alox axis is active and promotes development of AAA in wild-type mice with up-regulation of IL6/CCL2. The gene discussed is CCL2; the disease is triple-A syndrome.